Abomics

Booth 21

Description

Abomics is a Finnish health-tech company specializing in pharmacogenetics (PGx). Founded in 2013 by medical doctors, we support healthcare professionals in making safer, more effective medication decisions by turning genetic data into actionable clinical insight. Our pharmacogenetic solutions enable precision medication by identifying how individual genetic variation affects drug response and dosing. This reduces trial and error prescribing and lowers the risk of adverse drug reactions. Designed for real world healthcare settings, our solutions integrate seamlessly into existing clinical workflows, ensuring PGx information is available throughout a patient’s lifetime.